SU845779A3 - Способ получени производныхиМидАзОлиНА или ТЕТРАгидРОпиРиМидиНА,СМЕСи РАцЕМАТОВ,иНдиВидуАльНыХ РАцЕМАТОВ,ОпТичЕСКиХ АНТипОдОВ или иХ СОлЕй - Google Patents
Способ получени производныхиМидАзОлиНА или ТЕТРАгидРОпиРиМидиНА,СМЕСи РАцЕМАТОВ,иНдиВидуАльНыХ РАцЕМАТОВ,ОпТичЕСКиХ АНТипОдОВ или иХ СОлЕй Download PDFInfo
- Publication number
- SU845779A3 SU845779A3 SU792733999A SU2733999A SU845779A3 SU 845779 A3 SU845779 A3 SU 845779A3 SU 792733999 A SU792733999 A SU 792733999A SU 2733999 A SU2733999 A SU 2733999A SU 845779 A3 SU845779 A3 SU 845779A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- ethyl
- solution
- imidazoline
- urea
- aminoethyl
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 16
- 150000003839 salts Chemical class 0.000 title claims description 13
- 238000000034 method Methods 0.000 title claims description 6
- 230000003287 optical effect Effects 0.000 title claims description 6
- OTPDWCMLUKMQNO-UHFFFAOYSA-N 1,2,3,4-tetrahydropyrimidine Chemical compound C1NCC=CN1 OTPDWCMLUKMQNO-UHFFFAOYSA-N 0.000 title 1
- 150000002462 imidazolines Chemical class 0.000 title 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 78
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 31
- 239000000155 melt Substances 0.000 claims description 27
- -1 (2-anilinomethyl) -2-imidazolin-1-yl-ethyl Chemical group 0.000 claims description 24
- 239000002253 acid Substances 0.000 claims description 16
- 238000000354 decomposition reaction Methods 0.000 claims description 15
- 239000007858 starting material Substances 0.000 claims description 13
- 238000006243 chemical reaction Methods 0.000 claims description 11
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 9
- 150000007513 acids Chemical class 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 239000004202 carbamide Substances 0.000 claims description 7
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 6
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 5
- 239000011541 reaction mixture Substances 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 239000012948 isocyanate Substances 0.000 claims description 3
- 238000001953 recrystallisation Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- VRXQDECQRZYNJZ-UHFFFAOYSA-N n-[[1-(1-aminoethyl)-4,5-dihydroimidazol-2-yl]methyl]-2,6-dichloroaniline Chemical compound CC(N)N1CCN=C1CNC1=C(Cl)C=CC=C1Cl VRXQDECQRZYNJZ-UHFFFAOYSA-N 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 62
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 50
- 239000000243 solution Substances 0.000 claims 44
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 22
- 235000019439 ethyl acetate Nutrition 0.000 claims 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 17
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 claims 15
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 14
- 235000019441 ethanol Nutrition 0.000 claims 14
- 239000003513 alkali Substances 0.000 claims 12
- 239000002585 base Substances 0.000 claims 11
- MGYGFNQQGAQEON-UHFFFAOYSA-N 4-tolyl isocyanate Chemical compound CC1=CC=C(N=C=O)C=C1 MGYGFNQQGAQEON-UHFFFAOYSA-N 0.000 claims 10
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 claims 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 10
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 10
- 229910052708 sodium Inorganic materials 0.000 claims 10
- 239000011734 sodium Substances 0.000 claims 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 9
- 230000001476 alcoholic effect Effects 0.000 claims 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 7
- 239000002244 precipitate Substances 0.000 claims 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims 6
- 239000007789 gas Substances 0.000 claims 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims 6
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 claims 5
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 claims 5
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 5
- 238000002425 crystallisation Methods 0.000 claims 5
- 230000008025 crystallization Effects 0.000 claims 5
- 239000000047 product Substances 0.000 claims 5
- 238000010992 reflux Methods 0.000 claims 5
- 238000003756 stirring Methods 0.000 claims 5
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 claims 4
- 239000013078 crystal Substances 0.000 claims 4
- 239000000126 substance Substances 0.000 claims 4
- 239000000725 suspension Substances 0.000 claims 4
- TVOGFKKPKAUXME-UHFFFAOYSA-N 1-[2-(2-chlorophenyl)-4,5-dihydroimidazol-1-yl]ethanamine Chemical compound CC(N)N1CCN=C1C1=CC=CC=C1Cl TVOGFKKPKAUXME-UHFFFAOYSA-N 0.000 claims 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 3
- 229960000583 acetic acid Drugs 0.000 claims 3
- 229910021529 ammonia Inorganic materials 0.000 claims 3
- 230000015572 biosynthetic process Effects 0.000 claims 3
- HLVGAFHZUPLCML-UHFFFAOYSA-N ethyl 4-(carbamoylamino)benzoate Chemical compound CCOC(=O)C1=CC=C(NC(N)=O)C=C1 HLVGAFHZUPLCML-UHFFFAOYSA-N 0.000 claims 3
- CFEPCPHKICBCJV-UHFFFAOYSA-N ethyl 4-isocyanatobenzoate Chemical compound CCOC(=O)C1=CC=C(N=C=O)C=C1 CFEPCPHKICBCJV-UHFFFAOYSA-N 0.000 claims 3
- 239000000284 extract Substances 0.000 claims 3
- 238000010438 heat treatment Methods 0.000 claims 3
- 229910000037 hydrogen sulfide Inorganic materials 0.000 claims 3
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 claims 3
- 238000002844 melting Methods 0.000 claims 3
- 230000008018 melting Effects 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 229910000027 potassium carbonate Inorganic materials 0.000 claims 3
- LLAPDLPYIYKTGQ-UHFFFAOYSA-N 1-aminoethyl Chemical group C[CH]N LLAPDLPYIYKTGQ-UHFFFAOYSA-N 0.000 claims 2
- SXJYSIBLFGQAND-UHFFFAOYSA-N 1-isocyanato-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=CC(N=C=O)=C1 SXJYSIBLFGQAND-UHFFFAOYSA-N 0.000 claims 2
- UFFBMTHBGFGIHF-UHFFFAOYSA-N 2,6-dimethylaniline Chemical compound CC1=CC=CC(C)=C1N UFFBMTHBGFGIHF-UHFFFAOYSA-N 0.000 claims 2
- NHWQMJMIYICNBP-UHFFFAOYSA-N 2-chlorobenzonitrile Chemical compound ClC1=CC=CC=C1C#N NHWQMJMIYICNBP-UHFFFAOYSA-N 0.000 claims 2
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 2
- JYNVJWXDTVITNH-UHFFFAOYSA-N 3-(2-pyridin-4-yl-5,6-dihydro-4h-pyrimidin-1-yl)propan-1-amine Chemical compound NCCCN1CCCN=C1C1=CC=NC=C1 JYNVJWXDTVITNH-UHFFFAOYSA-N 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 claims 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 2
- 238000013019 agitation Methods 0.000 claims 2
- 239000012670 alkaline solution Substances 0.000 claims 2
- 239000003054 catalyst Substances 0.000 claims 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 claims 2
- 238000001816 cooling Methods 0.000 claims 2
- 238000004821 distillation Methods 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 2
- 125000004494 ethyl ester group Chemical group 0.000 claims 2
- 238000005187 foaming Methods 0.000 claims 2
- 239000012458 free base Substances 0.000 claims 2
- 239000012362 glacial acetic acid Substances 0.000 claims 2
- 230000001376 precipitating effect Effects 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- GPHQHTOMRSGBNZ-UHFFFAOYSA-N pyridine-4-carbonitrile Chemical compound N#CC1=CC=NC=C1 GPHQHTOMRSGBNZ-UHFFFAOYSA-N 0.000 claims 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 claims 2
- OZANUADAOVTFPU-UHFFFAOYSA-N (2,6-dimethylpyrimidin-4-yl)thiourea Chemical compound CC1=CC(NC(N)=S)=NC(C)=N1 OZANUADAOVTFPU-UHFFFAOYSA-N 0.000 claims 1
- DMSHKWHLXNDUST-UHFFFAOYSA-N (4-methylphenyl)urea Chemical compound CC1=CC=C(NC(N)=O)C=C1 DMSHKWHLXNDUST-UHFFFAOYSA-N 0.000 claims 1
- YJLHOLHUFOHNGF-UHFFFAOYSA-N 1-(2-benzyl-4,5-dihydroimidazol-1-yl)ethanamine Chemical compound CC(N)N1CCN=C1CC1=CC=CC=C1 YJLHOLHUFOHNGF-UHFFFAOYSA-N 0.000 claims 1
- BUDULDOEFHYROX-UHFFFAOYSA-N 1-(4-methoxyphenyl)-4,5-dihydroimidazole Chemical compound C1=CC(OC)=CC=C1N1C=NCC1 BUDULDOEFHYROX-UHFFFAOYSA-N 0.000 claims 1
- FCUZQTJOIHQQAO-UHFFFAOYSA-N 1-[2-(4-methoxyphenyl)-4,5-dihydroimidazol-1-yl]ethanamine Chemical compound C1=CC(OC)=CC=C1C1=NCCN1C(C)N FCUZQTJOIHQQAO-UHFFFAOYSA-N 0.000 claims 1
- HHIRBXHEYVDUAM-UHFFFAOYSA-N 1-chloro-3-isocyanatobenzene Chemical compound ClC1=CC=CC(N=C=O)=C1 HHIRBXHEYVDUAM-UHFFFAOYSA-N 0.000 claims 1
- MTFFANYLEXKMTD-UHFFFAOYSA-N 1-hydroxy-1-phenylurea Chemical compound NC(=O)N(O)C1=CC=CC=C1 MTFFANYLEXKMTD-UHFFFAOYSA-N 0.000 claims 1
- XBMDURKXQNCJIV-UHFFFAOYSA-N 2-(2,6-dichloroanilino)acetonitrile Chemical compound ClC1=CC=CC(Cl)=C1NCC#N XBMDURKXQNCJIV-UHFFFAOYSA-N 0.000 claims 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 claims 1
- VTYDEWDXIBGHMP-UHFFFAOYSA-N 2-(4-chloroanilino)acetonitrile Chemical compound ClC1=CC=C(NCC#N)C=C1 VTYDEWDXIBGHMP-UHFFFAOYSA-N 0.000 claims 1
- KAXCEFLQAYFJKV-UHFFFAOYSA-N 2-anilinoacetonitrile Chemical compound N#CCNC1=CC=CC=C1 KAXCEFLQAYFJKV-UHFFFAOYSA-N 0.000 claims 1
- FFNVQNRYTPFDDP-UHFFFAOYSA-N 2-cyanopyridine Chemical compound N#CC1=CC=CC=N1 FFNVQNRYTPFDDP-UHFFFAOYSA-N 0.000 claims 1
- FSTPMFASNVISBU-UHFFFAOYSA-N 2-methoxybenzonitrile Chemical compound COC1=CC=CC=C1C#N FSTPMFASNVISBU-UHFFFAOYSA-N 0.000 claims 1
- KVXWXTUEQFMPSU-UHFFFAOYSA-N 4-(4,5-dihydroimidazol-1-yl)pyridine Chemical compound C1CN(C=N1)C1=CC=NC=C1 KVXWXTUEQFMPSU-UHFFFAOYSA-N 0.000 claims 1
- ZNDANSYLTARWDU-UHFFFAOYSA-N 4-(ethylcarbamoylamino)benzoic acid Chemical compound CCNC(=O)NC1=CC=C(C(O)=O)C=C1 ZNDANSYLTARWDU-UHFFFAOYSA-N 0.000 claims 1
- KKHMQRRQQBALFL-UHFFFAOYSA-N 4-isocyanatobenzoic acid Chemical compound OC(=O)C1=CC=C(N=C=O)C=C1 KKHMQRRQQBALFL-UHFFFAOYSA-N 0.000 claims 1
- XDJAAZYHCCRJOK-UHFFFAOYSA-N 4-methoxybenzonitrile Chemical compound COC1=CC=C(C#N)C=C1 XDJAAZYHCCRJOK-UHFFFAOYSA-N 0.000 claims 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- BCASFWQXDSQOMP-UHFFFAOYSA-N CCC1=CC(N=C=O)=CC=C1C(O)=O Chemical compound CCC1=CC(N=C=O)=CC=C1C(O)=O BCASFWQXDSQOMP-UHFFFAOYSA-N 0.000 claims 1
- RQHPPMOMJPCDGK-UHFFFAOYSA-N CCN(C(=O)NC1=CC=C(C=C1)C)N2CCN=C2CC3=CC=CC=C3 Chemical compound CCN(C(=O)NC1=CC=C(C=C1)C)N2CCN=C2CC3=CC=CC=C3 RQHPPMOMJPCDGK-UHFFFAOYSA-N 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 1
- QPFYXYFORQJZEC-FOCLMDBBSA-N Phenazopyridine Chemical compound NC1=NC(N)=CC=C1\N=N\C1=CC=CC=C1 QPFYXYFORQJZEC-FOCLMDBBSA-N 0.000 claims 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 1
- ITLNWESJVXRWPP-UHFFFAOYSA-N acetonitrile 2,6-dimethylaniline Chemical compound CC#N.Cc1cccc(C)c1N ITLNWESJVXRWPP-UHFFFAOYSA-N 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 claims 1
- 229940058307 antinematodal tetrahydropyrimidine derivative Drugs 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 239000002026 chloroform extract Substances 0.000 claims 1
- 238000011097 chromatography purification Methods 0.000 claims 1
- 229910052802 copper Inorganic materials 0.000 claims 1
- 239000010949 copper Substances 0.000 claims 1
- 239000012043 crude product Substances 0.000 claims 1
- 235000005911 diet Nutrition 0.000 claims 1
- 230000037213 diet Effects 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- BDTDECDAHYOJRO-UHFFFAOYSA-N ethyl n-(sulfanylidenemethylidene)carbamate Chemical compound CCOC(=O)N=C=S BDTDECDAHYOJRO-UHFFFAOYSA-N 0.000 claims 1
- JAVGXICXKOGOQF-UHFFFAOYSA-N ethyl n-[(2,6-dimethylpyrimidin-4-yl)carbamothioyl]carbamate Chemical compound CCOC(=O)NC(=S)NC1=CC(C)=NC(C)=N1 JAVGXICXKOGOQF-UHFFFAOYSA-N 0.000 claims 1
- 238000001704 evaporation Methods 0.000 claims 1
- 230000008020 evaporation Effects 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 239000000706 filtrate Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 1
- 125000001841 imino group Chemical group [H]N=* 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- CKFGINPQOCXMAZ-UHFFFAOYSA-N methanediol Chemical compound OCO CKFGINPQOCXMAZ-UHFFFAOYSA-N 0.000 claims 1
- DGEYTDCFMQMLTH-UHFFFAOYSA-N methanol;propan-2-ol Chemical compound OC.CC(C)O DGEYTDCFMQMLTH-UHFFFAOYSA-N 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 229940050176 methyl chloride Drugs 0.000 claims 1
- PJKPMWNNAYBKMQ-UHFFFAOYSA-N n-[[1-(1-aminoethyl)-4,5-dihydroimidazol-2-yl]methyl]-2,6-dimethylaniline;dihydrochloride Chemical compound Cl.Cl.CC(N)N1CCN=C1CNC1=C(C)C=CC=C1C PJKPMWNNAYBKMQ-UHFFFAOYSA-N 0.000 claims 1
- NOWLBFMSDPRQFL-UHFFFAOYSA-N n-[[1-(1-aminoethyl)-4,5-dihydroimidazol-2-yl]methyl]-4-chloroaniline Chemical compound CC(N)N1CCN=C1CNC1=CC=C(Cl)C=C1 NOWLBFMSDPRQFL-UHFFFAOYSA-N 0.000 claims 1
- XMYSHSUOSFMIBT-UHFFFAOYSA-N n-[[1-(1-aminoethyl)-4,5-dihydroimidazol-2-yl]methyl]aniline Chemical compound CC(N)N1CCN=C1CNC1=CC=CC=C1 XMYSHSUOSFMIBT-UHFFFAOYSA-N 0.000 claims 1
- XULSCZPZVQIMFM-IPZQJPLYSA-N odevixibat Chemical compound C12=CC(SC)=C(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(O)=O)C=3C=CC(O)=CC=3)C=C2S(=O)(=O)NC(CCCC)(CCCC)CN1C1=CC=CC=C1 XULSCZPZVQIMFM-IPZQJPLYSA-N 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims 1
- 229940083254 peripheral vasodilators imidazoline derivative Drugs 0.000 claims 1
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 claims 1
- SUSQOBVLVYHIEX-UHFFFAOYSA-N phenylacetonitrile Chemical compound N#CCC1=CC=CC=C1 SUSQOBVLVYHIEX-UHFFFAOYSA-N 0.000 claims 1
- HPOKESDSMZRZLC-UHFFFAOYSA-N propan-2-one;hydrochloride Chemical compound Cl.CC(C)=O HPOKESDSMZRZLC-UHFFFAOYSA-N 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 229940070891 pyridium Drugs 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
- 239000012047 saturated solution Substances 0.000 claims 1
- 238000009738 saturating Methods 0.000 claims 1
- 238000005245 sintering Methods 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 150000005326 tetrahydropyrimidines Chemical class 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- QXQAPNSHUJORMC-UHFFFAOYSA-N 1-chloro-4-propylbenzene Chemical compound CCCC1=CC=C(Cl)C=C1 QXQAPNSHUJORMC-UHFFFAOYSA-N 0.000 description 1
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229960004909 aminosalicylic acid Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical class OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- NLVXSWCKKBEXTG-UHFFFAOYSA-N vinylsulfonic acid Chemical compound OS(=O)(=O)C=C NLVXSWCKKBEXTG-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/22—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH251978 | 1978-03-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU845779A3 true SU845779A3 (ru) | 1981-07-07 |
Family
ID=4235609
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU792733999A SU845779A3 (ru) | 1978-03-08 | 1979-03-07 | Способ получени производныхиМидАзОлиНА или ТЕТРАгидРОпиРиМидиНА,СМЕСи РАцЕМАТОВ,иНдиВидуАльНыХ РАцЕМАТОВ,ОпТичЕСКиХ АНТипОдОВ или иХ СОлЕй |
| SU802872253A SU923367A3 (ru) | 1978-03-08 | 1980-01-18 | Способ получени производных имидазолина или их солей |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU802872253A SU923367A3 (ru) | 1978-03-08 | 1980-01-18 | Способ получени производных имидазолина или их солей |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US4292429A (enExample) |
| EP (1) | EP0004561B1 (enExample) |
| JP (1) | JPS54125668A (enExample) |
| KR (2) | KR820002098B1 (enExample) |
| AR (2) | AR225010A1 (enExample) |
| AT (1) | AT364375B (enExample) |
| AU (1) | AU531006B2 (enExample) |
| CS (1) | CS244656B2 (enExample) |
| CY (1) | CY1304A (enExample) |
| DD (1) | DD142336A5 (enExample) |
| DE (1) | DE2961198D1 (enExample) |
| DK (1) | DK95279A (enExample) |
| ES (1) | ES478342A1 (enExample) |
| FI (1) | FI70708C (enExample) |
| GB (1) | GB2016011B (enExample) |
| GR (1) | GR71998B (enExample) |
| HK (1) | HK80185A (enExample) |
| HU (1) | HU182940B (enExample) |
| IL (1) | IL56797A (enExample) |
| MY (1) | MY8700199A (enExample) |
| NO (1) | NO152606C (enExample) |
| NZ (1) | NZ189841A (enExample) |
| OA (1) | OA06201A (enExample) |
| PH (1) | PH16207A (enExample) |
| PL (2) | PL116762B1 (enExample) |
| PT (1) | PT69314A (enExample) |
| SU (2) | SU845779A3 (enExample) |
| ZA (1) | ZA791062B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4338453A (en) | 1980-09-17 | 1982-07-06 | The Upjohn Company | Aminoalkyl-1,2,4-triazoles |
| US4353921A (en) * | 1981-06-19 | 1982-10-12 | Berlex Laboratories, Inc. | Antiarrythmic 1-arylcarbamoylalkyl-2-imidazoline derivatives, composition and method of use |
| DE3213509A1 (de) * | 1982-04-10 | 1983-10-20 | Basf Ag, 6700 Ludwigshafen | N-substituierte imidazol-derivate, ihre herstellung, diese enthaltende arzneimittel und ihre verwendung |
| JPS6133173A (ja) * | 1984-07-25 | 1986-02-17 | Torii Yakuhin Kk | アミジン化合物 |
| JPS62501922A (ja) * | 1984-12-12 | 1987-07-30 | エム・ティー・ディー メディカル テクノロジー アンド ディベロプメント リミテッド | 病室等の装備方法 |
| GB8906198D0 (en) * | 1989-03-17 | 1989-05-04 | Ciba Geigy Ag | Compounds |
| EP1879870A1 (en) * | 2005-05-03 | 2008-01-23 | Pharma Mar, S.A. | Antitumoral tetrahydro-pyrimidines |
| FR2901273B1 (fr) * | 2006-05-19 | 2010-12-24 | Anaconda Pharma | Inhibiteurs du virus du papillome humain et les compositions pharmaceutiques les contenant |
| WO2010032232A1 (en) | 2008-09-17 | 2010-03-25 | William Kingston | Tideway anchor system |
| WO2011108724A1 (ja) * | 2010-03-04 | 2011-09-09 | 味の素株式会社 | 糖尿病又は肥満症の予防又は治療剤 |
| PT2546231T (pt) * | 2010-03-04 | 2019-02-06 | Ea Pharma Co Ltd | Derivado de alquilamina |
| CN102924380B (zh) * | 2012-11-13 | 2014-12-31 | 齐鲁动物保健品有限公司 | 一种咪唑苯脲的制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH234990A (de) * | 1938-05-11 | 1944-10-31 | Chem Ind Basel | Verfahren zur Darstellung eines neuen therapeutisch wirksamen Amidins. |
| GB813525A (en) * | 1956-07-09 | 1959-05-21 | Socony Mobil Oil Co Inc | Fuel oil composition |
| GB1082964A (en) * | 1963-06-25 | 1967-09-13 | Wellcome Found | New substituted imidazolines and their preparation and use |
| US3455940A (en) * | 1965-12-07 | 1969-07-15 | Herbert C Stecker | Certain halo and dihalo n-substituted salicylamides |
| GB1174349A (en) * | 1966-08-25 | 1969-12-17 | Boehringer Sohn Ingelheim | Novel 2-Anilinomethylimidazoline Derivatives and process for the preparation thereof |
| US3846071A (en) * | 1969-02-12 | 1974-11-05 | Petrolite Corp | Process of inhibiting corrosion by treatment with phosphate-cyclic amidine salts |
| NL7415845A (nl) * | 1973-12-26 | 1975-06-30 | Upjohn Co | Werkwijze voor het bevorderen van de productie van endogene prostaglandinen door zoogdieren, alsmede werkwijze ter bereiding van daarbij te gebruiken preparaten. |
| US4088766A (en) * | 1975-06-25 | 1978-05-09 | The Upjohn Company | Urea containing compositions and methods |
| US4233451A (en) * | 1976-05-20 | 1980-11-11 | The Procter & Gamble Company | Process for making imidazolinium salts |
| US4353921A (en) * | 1981-06-19 | 1982-10-12 | Berlex Laboratories, Inc. | Antiarrythmic 1-arylcarbamoylalkyl-2-imidazoline derivatives, composition and method of use |
-
1979
- 1979-02-23 US US06/014,661 patent/US4292429A/en not_active Expired - Lifetime
- 1979-03-05 DE DE7979100647T patent/DE2961198D1/de not_active Expired
- 1979-03-05 EP EP79100647A patent/EP0004561B1/de not_active Expired
- 1979-03-05 FI FI790740A patent/FI70708C/fi not_active IP Right Cessation
- 1979-03-05 CS CS791460A patent/CS244656B2/cs unknown
- 1979-03-06 OA OA56752A patent/OA06201A/xx unknown
- 1979-03-06 IL IL56797A patent/IL56797A/xx unknown
- 1979-03-06 PL PL1979213924A patent/PL116762B1/pl unknown
- 1979-03-06 DD DD79211405A patent/DD142336A5/de unknown
- 1979-03-06 PL PL1979221681A patent/PL123150B1/pl unknown
- 1979-03-06 KR KR7900682A patent/KR820002098B1/ko not_active Expired
- 1979-03-06 ES ES478342A patent/ES478342A1/es not_active Expired
- 1979-03-07 GB GB7908098A patent/GB2016011B/en not_active Expired
- 1979-03-07 CY CY1304A patent/CY1304A/en unknown
- 1979-03-07 NO NO790765A patent/NO152606C/no unknown
- 1979-03-07 DK DK95279A patent/DK95279A/da not_active Application Discontinuation
- 1979-03-07 SU SU792733999A patent/SU845779A3/ru active
- 1979-03-07 AT AT0171079A patent/AT364375B/de not_active IP Right Cessation
- 1979-03-07 NZ NZ189841A patent/NZ189841A/xx unknown
- 1979-03-07 GR GR58542A patent/GR71998B/el unknown
- 1979-03-07 HU HU79CI1920A patent/HU182940B/hu unknown
- 1979-03-07 AU AU44900/79A patent/AU531006B2/en not_active Ceased
- 1979-03-07 ZA ZA791062A patent/ZA791062B/xx unknown
- 1979-03-07 PT PT69314A patent/PT69314A/pt unknown
- 1979-03-07 PH PH22264A patent/PH16207A/en unknown
- 1979-03-08 JP JP2624579A patent/JPS54125668A/ja active Granted
- 1979-03-18 AR AR275744A patent/AR225010A1/es active
-
1980
- 1980-01-18 SU SU802872253A patent/SU923367A3/ru active
- 1980-07-17 AR AR281806A patent/AR227286A1/es active
-
1981
- 1981-03-25 US US06/247,427 patent/US4420619A/en not_active Expired - Fee Related
-
1982
- 1982-09-08 KR KR1019820004065A patent/KR830000884B1/ko not_active Expired
-
1985
- 1985-10-17 HK HK801/85A patent/HK80185A/xx unknown
-
1987
- 1987-12-30 MY MY199/87A patent/MY8700199A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU845779A3 (ru) | Способ получени производныхиМидАзОлиНА или ТЕТРАгидРОпиРиМидиНА,СМЕСи РАцЕМАТОВ,иНдиВидуАльНыХ РАцЕМАТОВ,ОпТичЕСКиХ АНТипОдОВ или иХ СОлЕй | |
| US5731311A (en) | N,N-di(aryl) cyclic urea derivatives as anti-coagulants | |
| US4351939A (en) | Spiro-quaternary ammonium halides and N-(2-pyrimidinyl)piperazinylalkylazaspiroalkanedione process | |
| PL171512B1 (pl) | Sposób wytwarzania nowych pirydylopochodnych PL | |
| US4305944A (en) | N-[(4-[3-cyano substituted pyridyl]piperazino)alkyl]-azaspirodecanediones | |
| KR20010024258A (ko) | 포스포리파제 저해제로 사용되는9,10-디히드로-9,10-에타노안트라센 유도체 | |
| US4504482A (en) | [5(or 4)-(Pyridinyl)-2-pyrimidinyl]ureas and cardiotonic use thereof | |
| US3565896A (en) | Pyridinecarbonyl derivatives of 7-(omega-(n-alkyl-n-optionally hydroxyalkyl substituted amino) - hydroxyalkyl)theophylline | |
| US3201406A (en) | Pyridylcoumarins | |
| EP0117345B1 (en) | Aminopyrimidinones as histamine h2-antagonists | |
| CA1166253A (en) | 4-amino-6-(pyridinyl)-3(2h)-pyridazinones, preparation and cardiotonic use | |
| US3378564A (en) | Certain pyridyl tetrazole derivatives | |
| CS274445B2 (en) | Method of new trisubstituted amines production | |
| US4417049A (en) | Spiro-quaternary ammonium halides and N-(2-pyrimidinyl)piperazinylalkylazaspiroalkanedione process | |
| US4346221A (en) | Preparation of 4-amino-6-(pyridinyl)-3(2H)-pyridazinones from 6-(pyridinyl)-3(2H)-pyridazinones | |
| US4620002A (en) | 2-pyrimidyl alkanesulfonates | |
| CA1166254A (en) | 4-substituted-6-(pyridinyl)-3(2h)-pyridazinones, preparation and cardiotonic use | |
| CA1125759A (en) | Process for the preparation of novel urea and amido compounds | |
| US4337253A (en) | 4,5-Dihydro-2-methyl-6-(4-pyridinyl)-3(2H)-pyridazinone and its use as a cardiotonic | |
| JPS61280475A (ja) | 窒素含有複素環のアルキル側鎖を塩素化する方法 | |
| SU430554A1 (ru) | Способ получения производных 2,3-бензоксазепина | |
| NL192109C (nl) | Kristallijne iminiumzouten, werkwijze ter bereiding daarvan, cardiotonische preparaten die deze zouten bevatten, alsmede hun toepassing ter bereiding van bypiridinonderivaten. | |
| US3123606A (en) | T-alkylaminoalkyl | |
| US4338446A (en) | Di-(lower-alkyl)hydroxy-[2-oxo-2-(pyridinyl)ethyl]-propanedioates | |
| SU448645A1 (ru) | Способ получени производных имидазолидинона |